Michael Scolaro

Michael Scolaro

Aug 28, 2017

Group 6 Copy 196
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Do fungi exposed to toxic waste produce novel antimicrobial agents?

    We've discovered a few new mushrooms thriving in this harsh environment of land-disposed sewage sludge in...

    A Prescription for Health and Fitness Based on Your Genes

    Exercise has many health benefits. Yet, most people stop their exercise programs after they start them...

    Modeling Zika virus transmission from mother to child using uterine mini-organs

    As of mid-2019, 87 countries have had or still have Zika cases, underlining the importance of this infectious...

    Backer Badge Funded